Navigation Links
West Michigan's Newest Medical Device Company Receives Support from the West Michigan Science & Technology Initiative and EDF Ventures
Date:11/10/2008

GRAND RAPIDS, Mich., Nov. 10 /PRNewswire/ -- The West Michigan Science & Technology Initiative and EDF Ventures today announced the incorporation and financing of a new medical device company, TransCorp, Inc. TransCorp is temporarily located at the West Michigan Science & Technology offices in Grand Valley State University's Cook-DeVos Center for Health Sciences. The company will work to develop and commercialize novel surgical instruments and implants. Other participants in the financing include the Grand Angels, and Hopen Therapeutics, LLC.

EDF provided the necessary business counsel to take their company to the next level. The Initiative provided the new company with needed office space.

"Mike DeVries at EDF is clearly one of the leading medical device investors in this region," said David Lowry, M.D., TransCorp founder. "Mike knows the medical device space very well, and EDF has a proven track record as a solid investor."

"Supporting innovative companies like TransCorp is a vital component to what we do every day," said Linda Chamberlain, executive director of the West Michigan Science & Technology Initiative. "We are happy that we were able to provide the space they needed to get started and make any connections or collaborate with other clients and tenants to help TransCorp achieve their goals."

TransCorp was co-founded by David Lowry, M.D., a neurosurgeon with the Brain + Spine Center in Holland, Mich., Scott Tuinstra, PA-C, a physician assistant with the Brain + Spine Center, Roger Veldman, associate professor of engineering in the Department of Engineering at Hope College and Des O'Farrell who will serve as president of the new company.

Additionally, Mike DeVries of EDF Ventures and Mark Olesnvage of Hopen Therapeutics have been named to the TransCorp board of directors. DeVries will serve as chairman of the board.

"Mike and the EDF team understand the needs of seed and early stage companies, and they bring a wealth of knowledge to TransCorp," added Lowry. "Mike has an excellent network, and will be actively adding value as chairman of the board."

"Innovation in medical devices and the venture capital investments that support them are a vital component to West Michigan's long-term economic success," said Birgit Klohs, president and CEO of The Right Place, Inc., a leading economic development organization in West Michigan.

About EDF Ventures

EDF Ventures (http://www.edfvc.com) is a leading venture capital firm investing in early-stage health care companies. EDF focuses on young companies that are developing breakthrough technologies to address recognized problems or transform existing markets. EDF has offices in Grand Rapids and Ann Arbor, Mich.

About West Michigan Science & Technology Initiative

The West Michigan Science & Technology Initiative (http://www.wmsti.org) is a partnership among Grand Valley State University, Van Andel Research Institute, the City of Grand Rapids, Grand Rapids Community College, The Right Place, Inc., and health care providers and educators. The Initiative is dedicated to creating an environment that advances innovation and supports the commercialization of life sciences ideas, products and technologies. Since its inception, the Initiative has assisted more than 300 clients in commercialization of new products, including funding through receipt of more than $9 million in federal and state grant awards. The Initiative supports projects and creation of businesses that build regional life sciences commercialization infrastructure in West Michigan.


'/>"/>
SOURCE EDF Ventures
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Pharsight Welcomes Newest Japanese PKS, AutoPilot Customer
2. Gynecologic Oncologist, With Board Certification in GYN Oncology, OB/GYN, and Surgery Offers Women With Cancer the Newest Treatment Frontier: the Surgical Robot
3. SciQuest Announces Newest Life Sciences Customer; BioMarin Pharmaceutical Drives Spending Effectiveness with Automated, Intuitive Procurement
4. ThirdBiotech Announces Kemeta as Newest Sponsor
5. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
6. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
7. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
8. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
9. BioMS Medical announces its intention to renew a normal course issuer bid
10. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
11. ATS Medical Expands Open Pivot Heart Valve Offerings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... OXFORD, England , December 8, 2016 /PRNewswire/ ... (OGT), das Unternehmen für Molekulargenetik, erweitert seine Palette ... SureSeq myPanel™ NGS Custom FH Panels, das ein ... Hypercholesterinämie (FH) ermöglicht. Das Panel bietet eine Erkennung ... Number Variations (CNV) mit einem einzigen kleinen Panel ...
(Date:12/8/2016)... ... December 08, 2016 , ... KBioBox ... response to client demand KbioBox developed a sophisticated “3 click” gene dditing off ... accessible from KBioBox’s new website, https://www.kbiobox.com/ and powered by the ...
(Date:12/8/2016)... ... ... This CAST literature review and report looks at problems caused by the current ... in countries that are major global commodity exporters and importers, which show that asynchrony ... level presence (LLP) puts large volumes of trade worth billions of dollars at risk. ...
(Date:12/8/2016)... TAMPA, Fla. , Dec. 8, 2016 /PRNewswire/ ... biopharmaceutical company that discovers, develops and plans to ... today that its shares of common stock were approved ... stock will begin trading on the OTCQX, effective ... To qualify for the OTCQX market, companies must ...
Breaking Biology Technology:
(Date:11/29/2016)... 2016   Neurotechnology , a provider ... technologies, today released FingerCell 3.0, a software ... that run on low-power, low-memory microcontrollers. FingerCell ... than 128KB of memory, enabling it to ... limited on-board resources, such as: mobile phones, ...
(Date:11/22/2016)... 2016 According to the new market research report ... Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), Function (Contact and Non-contact), ... market is expected to grow from USD 10.74 Billion in 2015 to ... 2016 and 2022. Continue Reading ... ...
(Date:11/17/2016)... , Nov. 17, 2016 Global Market Watch: ... Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market is to ... for Private Biobanks shows the highest Compounded Annual Growth Rate ... region during the analysis period 2014-2020. North ... of 9.95% followed by Europe at ...
Breaking Biology News(10 mins):